Diabetes may be one of the nation’s leading causes of death, but knowing the facts can help you understand and avert the onset of the most common form of diabetes, type 2. Education is power to fight the deadly consequences of diabetes, and Dr. Schwartz identifies what you need to know.
Together with colleagues in Barcelona, researchers at the University of North Carolina at Chapel Hill have generated a complete map of the areas of the genome that control which genes are “turned on” or “off.” The discovery, made in pancreatic islet cells, opens new avenues for understanding the genetic basis of type 2 diabetes and other common illnesses.
While diabetes and hypertension ranked high for both groups, patients were more likely than doctors to prioritize symptoms such as pain and depression.
New collaboration leverages Joslin’s deep clinical and research expertise and dLife’s community and lifestyle approach to managing diabetes.
Type 2 diabetes is the silent killer...leading to heart disease and stroke. Some things to look out for and ways to prevent it.
In patients with type 2 diabetes, silent cerebral infarction (SCI)—small areas of brain damage caused by injury to small blood vessels—signals an increased risk of progressive kidney disease and kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).
A new treatment that could one day benefit burns victims, diabetes sufferers and the elderly – by fast tracking the healing of chronic wounds – has taken another step toward commercialization.
Clinical and basic science researchers from around the world will convene in Hong Kong from January 28 to 30 for the First International Congress on Abdominal Obesity: “Bridging the Gap between Cardiology and Diabetology.” The congress, sponsored by the International Chair on Cardiometabolic Risk (ICCR) (www.cardiometabolic-risk.org), is the first-ever specialized forum for sharing new insights and evidence about abdominal obesity and its clinical and public health implications.
In people who put on a lot of weight, or whose bodies start developing the inability to use insulin effectively that leads toward type 2 diabetes, the pancreas typically ramps up its supply of insulin-generating “beta” cells. Researchers at Joslin Diabetes Center and their colleagues now have identified a cell-cycle protein that is essential for beta-cell replication to respond successfully to insulin resistance. The finding may point toward eventual therapies for preventing or treating type 2 diabetes.
The neuropeptide corticotropin-releasing factor (CRF) makes cameo appearances throughout the body, but its leading role is as the opening act in the stress response, jump-starting the process along the hypothalamus-pituitary-adrenal (HPA) axis. Researchers at the Salk Institute for Biological Studies have found that CRF also plays a part in the pancreas, where it increases insulin secretion and promotes the division of the insulin-producing beta cells.
Patients who ordered their medications by mail were more likely to take them as prescribed by their physicians than patients who obtained medications from a local pharmacy.
A new evidence review suggests that using a pump to deliver insulin continuously — instead of taking three or more daily injections — might result in better control of blood sugar for people with type 1 diabetes.
Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, according to a study conducted by researchers at the University of Chicago.
The cardiovascular risk that is associated with proteinuria, or high levels of protein in the urine, a common test used by doctors as an indicator of increased risk for progressive kidney disease, heart attack and stroke, has race-dependent effects, according to a new study by researchers at Wake Forest University School of Medicine.
Medicare recipients with diabetes who have a gap in their Part D prescription drug benefits have higher out-of-pocket drug costs and are less likely to stick to their medications than those who have supplemental drug benefits.
A multi-disciplinary team of Penn researchers, including diabetes, weight loss and bariatric surgery experts, are conducting a study funded by the National Institutes of Health (NIH) to determine if bariatric surgery, either gastric bypass or adjustable gastric banding surgery, is more effective than lifestyle modification to reduce weight and ultimately treat Type 2 diabetes.
Bariatric surgery is a procedure designed to help patients lose weight, but what may be even more important is that it can also help resolve diabetes for patients with this disease.
Cigarette smoking is a well-known risk factor for type 2 diabetes, but new research from Johns Hopkins suggests that quitting the habit may actually raise diabetes risk in the short term.
In an annual supplement to the journal Diabetes Care, published Dec. 29 by the American Diabetes Association, the A1C test is given a prominent role in the 2010 guidelines for diabetes screening, diagnosis and prevention.
Researchers at the University of North Carolina at Chapel Hill School of Medicine say a recent discovery suggests that inherited genetic variations exist between whites and blacks living in the U.S., leading to less efficient metabolism of glucose and predisposition to diabetes in blacks.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right